$TMTC
TMT Acquisition Corp

2024 Q3 Form 10-Q Financial Statement

#000149315224033139 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $290.5K
YoY Change 123.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $290.5K
YoY Change 123.43%
Operating Profit -$290.5K
YoY Change 117.05%
Interest Expense $597.7K
YoY Change -0.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $307.2K
YoY Change -34.63%
Income Tax
% Of Pretax Income
Net Earnings $307.2K
YoY Change -34.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.04
COMMON SHARES
Basic Shares Outstanding 8.140M shares 8.140M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $680.00
YoY Change -99.43%
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets $82.41K
YoY Change -25.08%
Inventory
Prepaid Expenses $82.41K
Receivables
Other Receivables
Total Short-Term Assets $83.09K
YoY Change -68.6%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $65.46M
YoY Change 5.92%
Other Assets
YoY Change
Total Long-Term Assets $65.46M
YoY Change 5.86%
TOTAL ASSETS
Total Short-Term Assets $83.09K
Total Long-Term Assets $65.46M
Total Assets $65.54M
YoY Change 5.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $679.0K
YoY Change 440.58%
Deferred Revenue
YoY Change
Short-Term Debt $800.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.623M
YoY Change 1097.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.623M
Total Long-Term Liabilities $0.00
Total Liabilities $1.623M
YoY Change 1097.07%
SHAREHOLDERS EQUITY
Retained Earnings -$1.540M
YoY Change 539.4%
Common Stock $214.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.540M
YoY Change
Total Liabilities & Shareholders Equity $65.54M
YoY Change 5.55%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $307.2K
YoY Change -34.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $770.00
YoY Change -100.37%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$600.0K
YoY Change
Cash From Investing Activities -$600.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K
YoY Change
NET CHANGE
Cash From Operating Activities 770.0
Cash From Investing Activities -600.0K
Cash From Financing Activities 300.0K
Net Change In Cash -299.2K
YoY Change 42.49%
FREE CASH FLOW
Cash From Operating Activities $770.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
TMTCU Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
usd
TMTCU Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
1395429 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
307241 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
468703 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001879851
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
TMT Acquisition Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
420 Lexington Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2446
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10170
dei City Area Code
CityAreaCode
(347)
dei Local Phone Number
LocalPhoneNumber
627-0058
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8140000 shares
CY2024Q2 us-gaap Cash
Cash
683 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
82405 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
83088 usd
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
65455907 usd
CY2024Q2 us-gaap Assets
Assets
65538995 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
678953 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1623178 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1623178 usd
CY2024Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
65455907 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1540304 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65538995 usd
CY2024Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
TMTCU Payment Of Underwriting Discount
PaymentOfUnderwritingDiscount
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
TMTCU Note Payable To Related Party Converted To Subscription Of Private Placement
NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement
usd
TMTCU Receivable From Related Party For Purchase Of Private Placement
ReceivableFromRelatedPartyForPurchaseOfPrivatePlacement
usd
TMTCU Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
usd
TMTCU Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
usd
TMTCU Issuance Of Representative Shares At Fair Value
IssuanceOfRepresentativeSharesAtFairValue
usd
TMTCU Forfeiture Of Ordinary Shares
ForfeitureOfOrdinaryShares
usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-41667
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2023Q4 us-gaap Cash
Cash
46778 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
59531 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
106309 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
63460478 usd
CY2023Q4 us-gaap Assets
Assets
63566787 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
399020 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
409020 usd
CY2023Q4 us-gaap Liabilities
Liabilities
409020 usd
CY2024Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
6000000 shares
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
6000000 shares
CY2024Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
10.91
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
10.58
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
63460478 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2140000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2140000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2140000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2140000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
214 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
214 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302925 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1540090 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-302711 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63566787 usd
CY2023Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
60000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
40000 usd
CY2024Q2 us-gaap Direct Operating Costs
DirectOperatingCosts
260460 usd
CY2023Q2 us-gaap Direct Operating Costs
DirectOperatingCosts
103823 usd
us-gaap Direct Operating Costs
DirectOperatingCosts
577379 usd
us-gaap Direct Operating Costs
DirectOperatingCosts
191003 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-290460 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-133823 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-637379 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-231003 usd
CY2024Q2 TMTCU Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
597701 usd
CY2023Q2 TMTCU Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
602526 usd
TMTCU Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
602526 usd
us-gaap Net Income Loss
NetIncomeLoss
758050 usd
us-gaap Net Income Loss
NetIncomeLoss
371523 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-302711 usd
CY2024Q1 TMTCU Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
-797728 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
450809 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-649630 usd
CY2024Q2 TMTCU Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
-1197701 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
307241 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1540090 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15103 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60000000 usd
CY2023Q1 TMTCU Stock Issued During Period Value Proceeds From Sale Of Private Placement Units
StockIssuedDuringPeriodValueProceedsFromSaleOfPrivatePlacementUnits
3700000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-1200000 usd
CY2023Q1 TMTCU Stock Issued During Period Value Representative Shares Issued
StockIssuedDuringPeriodValueRepresentativeSharesIssued
1741500 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2668701 usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-58645200 usd
CY2023Q1 TMTCU Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
3781346 usd
CY2023Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-6336146 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-97180 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
290722 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
290722 usd
CY2023Q2 TMTCU Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
-602526 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
468703 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
468703 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
156899 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
156899 usd
us-gaap Net Income Loss
NetIncomeLoss
758050 usd
us-gaap Net Income Loss
NetIncomeLoss
371523 usd
TMTCU Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
1395429 usd
TMTCU Income From Investments Held In Trust Account
IncomeFromInvestmentsHeldInTrustAccount
602526 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
134225 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
10000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
22874 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
135011 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
279933 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
86977 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-246095 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-269037 usd
TMTCU Cash Deposited Into Trust Account
CashDepositedIntoTrustAccount
600000 usd
TMTCU Cash Deposited Into Trust Account
CashDepositedIntoTrustAccount
61200000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-600000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61200000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
60000000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3221664 usd
TMTCU Payment Of Underwriting Discount
PaymentOfUnderwritingDiscount
1200000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
500000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
483918 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
800000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61537746 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46095 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
68709 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46778 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47478 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
683 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116187 usd
TMTCU Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
2668701 usd
TMTCU Note Payable To Related Party Converted To Subscription Of Private Placement
NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement
444018 usd
TMTCU Receivable From Related Party For Purchase Of Private Placement
ReceivableFromRelatedPartyForPurchaseOfPrivatePlacement
34318 usd
TMTCU Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
3781346 usd
TMTCU Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
58645200 usd
TMTCU Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
1995429 usd
TMTCU Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
6336146 usd
TMTCU Issuance Of Representative Shares At Fair Value
IssuanceOfRepresentativeSharesAtFairValue
1741500 usd
TMTCU Forfeiture Of Ordinary Shares
ForfeitureOfOrdinaryShares
23 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-07-06
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
61200000 usd
CY2024Q2 TMTCU Transaction Costs
TransactionCosts
3868701 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
1200000 usd
CY2024Q2 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
2668701 usd
CY2024Q2 us-gaap Cash
Cash
683 usd
CY2024Q2 TMTCU Working Capital
WorkingCapital
1540090 usd
CY2024Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
600000 usd
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.10
us-gaap Interest Expense Deposits
InterestExpenseDeposits
1800000 usd
CY2024Q2 us-gaap Share Price
SharePrice
0.30
CY2024Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
800000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
800000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zBycAt5zGjQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zqholOxQ4h3e">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash
Cash
683 usd
CY2023Q4 us-gaap Cash
Cash
46778 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zi7zVvZiwIY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zfqAppNHVbd9">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zE25WWPuu3Ad" title="Cash FDIC insured amount">250,000</span>. As of June 30, 2024, and December 31, 2023, the Company did not experience losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
800000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
307241 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
468703 usd
us-gaap Net Income Loss
NetIncomeLoss
758050 usd
us-gaap Net Income Loss
NetIncomeLoss
371523 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-597701 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-602526 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1395429 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-602526 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
600000 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
600000 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
6336146 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-890460 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-133823 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1237379 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6567149 usd
CY2024Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.91
CY2022Q1 TMTCU Business Acquisitions Name Of Acquired Entity
BusinessAcquisitionsNameOfAcquiredEntity
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of their founder shares until the earlier of: (A) one year after the completion of the initial business combination or (B) subsequent to our business combination, the last sale price of the ordinary share (x) equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial business combination, or (y) the date following the completion of the initial business combination on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property.
CY2024Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
60000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
40000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2140000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2140000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2140000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2140000 shares
CY2023Q1 us-gaap Share Price
SharePrice
6.45

Files In Submission

Name View Source Status
0001493152-24-033139-index-headers.html Edgar Link pending
0001493152-24-033139-index.html Edgar Link pending
0001493152-24-033139.txt Edgar Link pending
0001493152-24-033139-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmtcu-20240630.xsd Edgar Link pending
tmtcu-20240630_cal.xml Edgar Link unprocessable
tmtcu-20240630_def.xml Edgar Link unprocessable
tmtcu-20240630_lab.xml Edgar Link unprocessable
tmtcu-20240630_pre.xml Edgar Link unprocessable